Why Idenix Pharmaceuticals Popped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Idenix Pharmaceuticals (Nasdaq: IDIX  ) have popped today by upwards of 18% after the company reported positive trial data on its hepatitis C drug.

So what: Idenix said a mid-stage trial of its drug candidates IDX184 and IDX719 saw positive results in 89% of patients that completed 12-week treatments. CEO Ron Renaud said that the company is looking forward to initiating interferon-free DAA combination studies in the near term.

Now what: The hepatitis C drug market is huge, so it's not surprising when good news like this boosts the company as much as it has. The market is expected to grow to $15 billion by 2019, which is largely why companies looking to get in on the ground floor have fared relatively well in recent times. If Idenix can grab just a piece of that pie, it will be just fine.

Interested in more info on Idenix Pharmaceuticals? Add it to your watchlist by clicking here.

Fool contributor Evan Niu holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1919076, ~/Articles/ArticleHandler.aspx, 8/22/2014 4:05:45 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 16,998.71 -40.78 -0.24%
S&P 500 1,988.47 -3.90 -0.20%
NASD 4,539.39 7.29 0.16%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
IDIX $0.00 Down +0.00 +0.00%
Idenix Pharmaceuti… CAPS Rating: **

Advertisement